APA (7th ed.) Citation

JJV, M., J, Ö., K, S., CB, G., P, H., EL, M., . . . Committees, C. I. a. (2003). Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: The CHARM-Added trial. Lancet, 362(9386), 767. https://doi.org/10.1016/s0140-6736(03)14283-3

Chicago Style (17th ed.) Citation

JJV, McMurray, et al. "Effects of Candesartan in Patients with Chronic Heart Failure and Reduced Left-ventricular Systolic Function Taking Angiotensin-converting-enzyme Inhibitors: The CHARM-Added Trial." Lancet 362, no. 9386 (2003): 767. https://doi.org/10.1016/s0140-6736(03)14283-3.

MLA (9th ed.) Citation

JJV, McMurray, et al. "Effects of Candesartan in Patients with Chronic Heart Failure and Reduced Left-ventricular Systolic Function Taking Angiotensin-converting-enzyme Inhibitors: The CHARM-Added Trial." Lancet, vol. 362, no. 9386, 2003, p. 767, https://doi.org/10.1016/s0140-6736(03)14283-3.